Navigation Links
Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies
Date:6/19/2013

Since FDA approval of the first PEGylated product, Adagen® (PEG-bovine adenosine deaminase) in 1990, cumulative worldwide revenue of all PEGylated pharmaceutical products  has exceeded $20 billion.  PEGylation has been validated for compounds including enzymes, peptides, small molecules and antibody fragments, with the chemical attachment of polyethylene glycol (PEG) used to improve those compounds' half lives and toxicity profiles, among other patient benefits achieved by maximizing the inherent biological activity of the native molecules.

About Belrose Pharma Inc.

Belrose Pharma Inc. (Princeton, NJ) is a specialty pharmaceutical company that operates two related businesses: (a) advancing development of internal clinical and pre-clinical compounds, and (b) product development for third party customers seeking to improve both early clinical and mid-lifecycle products using a range of  technologies including Customized Linker Technology®. Belrose combines a new senior commercial management team with a core technical team previously involved in development and commercialization efforts using customized PEGylation linker technologies.  Further information about Belrose can be found on the Company's website at www.belrosepharma.com.

Note to Media and Investors

Belrose Pharma has been formed by new investors to develop pharmaceutical products with technologies and clinical programs acquired from Enzon Pharmaceuticals and others.  The Belrose Pharma investors have no substantive relationship to any major equity or debt holder in Enzon Pharmaceuticals. Enzon Pharmaceuticals also does not have any equity ownership in Belrose Pharma.

Partnering Contact:

Michael King

Chief Commercial Officer

(609) 454-2989

michael.kin
'/>"/>

SOURCE Belrose Pharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
2. Pharma IQ Presents the Latest Trends in Clinical Trial Supply
3. Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes
4. Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Valeant Pharmaceuticals Prices Public Offering Of Common Shares
6. Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints
7. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
8. Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
9. Valeant Pharmaceuticals Announces Public Offering Of Common Shares
10. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
11. Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Lilly and Company (NYSE: LLY ) announced today the ... up to $1.6 billion aggregate principal amount of certain of ... tendered, and did not validly withdraw, their notes on or ... time, on May 27, 2015 (the early tender date), and ... receive the total consideration. The total consideration for each series ...
(Date:5/28/2015)... and HOUSTON , May 28, 2015 ... EPI) today reported financial results for the second quarter and ... specified otherwise, are expressed in Canadian dollars and in accordance ... Results ESSA recorded a net loss of ... ended March 31, 2015 (Q2-2015), compared to a net loss ...
(Date:5/28/2015)... Research and Markets ( ... Jain PharmaBiotech,s new report  "RNAi - Technologies, ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... the use of double stranded RNA (dsRNA). ... processed into short 21-23 nucleotide RNAs termed ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
... ( www.curemark.com ), a drug research and development company focused ... & Renshaw Annual Global Investment Conference held September 12-15 in ... 5,000 investors and other attendees.   "Curemark was ... present at the conference, which included a full roster of ...
... OmniComm Systems, Inc. (OTC Bulletin Board: ... and services announced that it will be hosting the ... Beach Resort in Fort Lauderdale, Florida from November 03-05, ... from participating Life Science organizations. The informal ambiance provides ...
Cached Medicine Technology:Curemark Presents at the Rodman & Renshaw Annual Global Investment Conference 2OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 2OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe is ... Joint Fluid Therapy (JFT) at their clinics in Orange ... injectable treatment that assists in diminishing pain for patients ... Dr. Stanley Katz and Dr. Neil Katz of Healthpointe. ... sodium hyaluronate (also known as hyaluronic acid) a natural ...
(Date:5/29/2015)... Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 29, 2015 ... in the vulvar region and can cause significant physical, ... understands the major life altering disorder of Vulvodynia. The ... exclusion. At Women’s Excellence in Endometriosis, they realize that ... If a patient is experiencing any of these symptoms, ...
(Date:5/29/2015)... The popular all-natural supplement brand, Liporidex, ... Select Program that gives bonuses to members for their ... 100 members per year, lucky members who are selected ... fitness experts at Nuretix Research, and get exclusive benefits ... they attain and maintain their weight loss and fitness ...
(Date:5/29/2015)... Louisville, KY (PRWEB) May 29, 2015 ... private and government entities to discuss and foster the ... data to improve health. The Conference is hosted by ... government, non-profit, and private organizations to promote and develop ... conference, there are several focused groups to narrow in ...
(Date:5/29/2015)... External Counterpulsation, also known as EECP ... patients. The Heart Fit Clinic is the first clinic in ... review from patients who are now completing treatment. , ... treatments of ECP treatment and received great results. His ... does the clinic perform this non-surgical treatment for heart disease, ...
Breaking Medicine News(10 mins):Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:Liporidex, a Sports Nutrition Supplement Brand, Is Searching For Members For Their Exclusive L-Style Select Program Which Rewards Members For Their Achievements 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2
... , , Web availability of ... CHARLESTON, S.C., Sept. 14 According to MUSC researchers, antibiotics ... despite efforts to control antibiotic-resistant bacteria as a result of misuse ... keyword search of "purchase antibiotics without a prescription" and "online" on ...
... , , , , ... A new critical illness plan from Colonial Life & Accident Insurance Company ... away from financial problems. Even with good health insurance, a serious illness, ... hook for huge expenses. , , "Even employees ...
... , , ROCKVILLE, Md., Sept. 14 ... Staying Active and Healthy with Blood Thinners , a new 10-minute ... to use anticoagulant drugs, commonly called blood thinners, safely. , ... thinners each year to reduce their risk of forming dangerous blood ...
... BOSTON, Sept. 14 Americans rate Alzheimer,s disease ... five million people living with this disease in the U.S. ... in the cause and prevention of Alzheimer,s disease, indicating that ... stave off this devastating illness. , , ...
... female patients , MONDAY, Sept. 14 (HealthDay News) -- ... with advanced heart failure. , A new analysis turns ... and then correct abnormal heart rhythms, actually lowered the ... that this is routine therapy for all patients with ...
... of other cancers, clots , MONDAY, Sept. 14 (HealthDay ... for developing breast cancer do reduce their cancer risk, ... analysis suggests. , That was the conclusion of researchers ... trials and a head-to-head assessment of the medications used ...
Cached Medicine News:Health News:MUSC Researchers Concerned About Online Drug Availability 2Health News:Critical Illness Plans Help Pay for What Health Insurance Won't 2Health News:Critical Illness Plans Help Pay for What Health Insurance Won't 3Health News:ahrq Announces New Video to Help Patients Use Blood Thinner Pills Safely and Effectively 2Health News:Senior Living Residences Launches Innovative Nutrition Program to Promote Cognitive Health and Lower the Risk of Alzheimer's Disease 2Health News:Implantable Defibrillators May Not Help Women With Heart Failure 2Health News:Implantable Defibrillators May Not Help Women With Heart Failure 3Health News:Medications That Lower Breast Cancer Risk Carry Other Dangers 2Health News:Medications That Lower Breast Cancer Risk Carry Other Dangers 3
... vascular tests for assessing peripheral vascular disease. With the Portable ABI Kit, you get the basic equipment ... ... ... The ankle-arm pressure index (also known as the Ankle/Brachial ...
... Clinitek Microalbumin Strips provide albumin, creatinine ... The Clinitek Microalbumin product is useful to ... or hypertension in order to detect early ... elevation of the urinary albumin excretion rate, ...
... today's busy physician's office environment, ... contribute to timing errors and ... strips are read visually. Studies ... is performed with an instrument, ...
... Ultra device consists of a non-compliant balloon ... mounted longitudinally on its outer surface. When ... the atherotomes score the plaque, creating initiation ... to as Atherotomy, allows dilatation of the ...
Medicine Products: